Structural Heart Devices Market is Growing Predominantly at a Well Being CAGR of 10.4% Duyring Forecast to 2023

Market Overview:

The structural heart devices market is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to provide the structural heart devices market opportunities.

the coming years. As per the latest report of Market Research Future (MRFR), the Structural Heart Devices Industry Share is poised to expand at CAGR of 10.4% over the forecast period. The structural heart devices market is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. The common structural heart diseases include ventricular septal defect, atrial septal defect, arterial/venous fistulae, paravalvular leak, congenital heart disease, and patent foramen oval. With advancements in the medical field, the open-heart surgical procedures have replaced with minimally invasive procedures like transcatheter mitral valve repair (TMVR) and transcatheter aortic valve replacement (TAVR).

Competitive Landscape:

·         Boston Scientific Corporation

·         Comed BV

·         Edwards Lifesciences Corporation

·         Cook Group Incorporated

·         Medtronic plc

·         W. L. Gore & Associates

·         Biomerics

·         Endologix Inc

·         ST. Jude Medical

·         LivaNova plc

·         CardioKinetix

·         JenaValve Technology

Segmentation:

·         The structural heart devices market has been segmented based on type, indication, procedure, and end-user.

·         By type, the structural heart devices market has been segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, accessories, and other devices.

·         By indication, the structural heart devices market has been segmented into valvular heart disease, cardiomyopathy, congenital heart defects, and others.

·         By procedure, the structural heart devices market has been segmented into Replacement Procedures and repair procedures.

·         By end-user, the structural heart devices market has been segmented into hospitals, ambulatory surgery centers, and others.

Regional Analysis:

Geographically, the structural heart devices market span across regions namely, Europe, America, Asia-Pacific, and the Middle East & Africa.

Among all the regions, the American region is considered to lead the global structural heart devices market. The increasing rate of surgeries due to high blood pressure, diabetes, and other factors contribute to the growth of the market. Moreover, growing healthcare awareness, medical tourism, technological advancements, and rising disposable income are likely to fuel the market growth in this region.

Europe is considered to hold the second largest position in the global market as structural heart devices market is most prevalent in Germany. Moreover, the increasing geriatric population, rising prevalence of obesity and diabetes are influencing the market growth in this region.

The Asia Pacific region is considered to be the fastest growing region owing to the increasing patient population, growing elderly population, and changing lifestyle. Such factors are considered to offer favorable backgrounds to the market growth.

Industry Updates

July 2019 - Abbott Laboratories, an American healthcare company, announced that its latest version of its heart device, dubbed MitraClip G4 had received FDA approval. The new heart device is equipped with advanced features that allow for customization of the mitral valve repair procedure.